O
2.62
-0.14 (-5.07%)
| 前收盘价格 | 2.76 |
| 收盘价格 | 2.75 |
| 成交量 | 2,055,159 |
| 平均成交量 (3个月) | 1,705,681 |
| 市值 | 257,759,104 |
| 价格/销量 (P/S) | 0.510 |
| 股市价格/股市净资产 (P/B) | 0.760 |
| 52周波幅 | |
| 利润日期 | 12 Mar 2026 |
| 营业毛利率 | -15.96% |
| 营业利益率 (TTM) | -9.49% |
| 稀释每股收益 (EPS TTM) | -0.700 |
| 季度收入增长率 (YOY) | 10.30% |
| 总债务/股东权益 (D/E MRQ) | 2,020.06% |
| 流动比率 (MRQ) | 1.79 |
| 营业现金流 (OCF TTM) | -15.64 M |
| 杠杆自由现金流 (LFCF TTM) | 5.58 M |
| 资产报酬率 (ROA TTM) | -17.66% |
| 股东权益报酬率 (ROE TTM) | -277.62% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Care Facilities (US) | 看涨 | 混合的 |
| Medical Care Facilities (全球的) | 看涨 | 看涨 | |
| 股票 | The Oncology Institute, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
0.0
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -3.5 |
| 平均 | 0.00 |
|
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services. |
|
| 部门 | Healthcare |
| 行业 | Medical Care Facilities |
| 投资方式 | Small Value |
| 内部持股比例 | 9.22% |
| 机构持股比例 | 34.63% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Josh Arnold Investment Consultant, Llc | 31 Dec 2025 | 2,459,809 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 7.00 (BTIG, 167.18%) | 购买 |
| 中 | 6.00 (129.01%) | |
| 低 | 5.00 (Needham, 90.84%) | 购买 |
| 平均值 | 6.00 (129.01%) | |
| 总计 | 2 购买 | |
| 平均价格@调整类型 | 2.73 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| BTIG | 09 Mar 2026 | 7.00 (167.18%) | 购买 | 2.73 |
| Needham | 09 Mar 2026 | 5.00 (90.84%) | 购买 | 2.73 |
该时间范围内无数据。
| 日期 | 类型 | 细节 |
|---|---|---|
| 12 Jan 2026 | 公告 | The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook |
| 09 Jan 2026 | 公告 | The Oncology Institute Announces Leadership Promotions |
| 05 Jan 2026 | 公告 | The Oncology Institute Announces Addition of Board Member Mark Stolper |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合